Moderna Stock Is Top Performer in S&P 500 Tuesday After Miserable 2023. Why This Year Could Be Better.
Share
Moderna stock was one of the worst performers in the S&P 500 last year as Covid-19 vaccine sales tumbled, but the vaccine maker has more to offer, according to Oppenheimer analysts.
Continue reading this article with a Barron’s subscription.
CD rates today, March 2, 2025 (up to 4.50% APY)
ARK Invest’s Cathie Wood: Nvidia is still a high-growth stock
Tractor Supply Company (TSCO) Stock Forecasts
Moderna Stock Is Top Performer in S&P 500 Tuesday After Miserable 2023. Why This Year Could Be Better.
Moderna stock was one of the worst performers in the S&P 500 last year as Covid-19 vaccine sales tumbled, but the vaccine maker has more to offer, according to Oppenheimer analysts.
Continue reading this article with a Barron’s subscription.
View Options
Source link
CD rates today, March 2, 2025 (up to 4.50% APY)
ARK Invest’s Cathie Wood: Nvidia is still a high-growth stock
Tractor Supply Company (TSCO) Stock Forecasts
Swiss banking rule delay a mixed blessing for UBS